This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Dermatology  • Dermatologic Disorders  • Cardiovascular System  • Rheumatology  • Rheumatoid Arthritis  • Dermatologic Disorders, Other  • Cardiovascular Disease/ Myocardial Infarction  • Drug Therapy  • Drug Therapy, Other  • Immunology  • Immunologic Disorders  • Alert me on articles by topic  Social Bookmarking   What's this?

Tamihiro Kawakami, MD, PhD; Masahide Yamazaki, MD, PhD; Kanade Kawasaki, MD, PhD; Masako Mizoguchi, MD, PhD; Yoshinao Soma, MD, PhD

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Rheumatoid vasculitis (RV) is an inflammatory condition of the small and medium-sized vessels that affects a subset of patients with established rheumatoid arthritis (RA). Detection of antiphospholipid cofactor antibodies including antiphosphatidylserine-prothrombin complex (aPS/PT) antibodies in addition to the classic anticardiolipin antibodies and lupus anticoagulant (LAC) seems to be of considerable clinical importance.¹ Argatroban is a synthetic monovalent direct anticoagulant and thrombin inhibitor.²

Report of a Case

A 70-year-old Japanese woman had a 35-year history of RA. Her disease had not responded well to treatment with intramuscular gold, methotrexate, D-penicillamine, azathioprine, or cyclosporine. She presented with a 2-week history of skin lesions with myalgias and arthralgias on her lower extremities. She complained of bilateral ankle numbness and a rapid increase in the intensity of her symptoms.

Examination revealed cutaneous ulcerations and livedo reticularis scattered . . . [Full Text of this Article]

Comment

AUTHOR INFORMATION


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?